Raptinal

Overview

Raptinal, a agent that directly activates caspase-3 , initiates intrinsic pathway caspase-dependent apoptosis . Raptinal is able to rapidly induce cancer cell death by directly activating the effector caspase-3 , bypassing the activation of initiator caspase-8 and caspase-9.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Caspase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-121320
• CAS No.: 1176-09-6
• Molecular Formula: C28H18O2
• Molecular Weight: 386.44
• Purity: 99.54%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.47 mM); Clear solution
• Availability: In-stock

Source

Original product source